Matthew Cobb
Family Medicine · Branson West, MONPI 1497866099
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $646, 2.8 times the $230 reported in 2019.
Across 123 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$276
- AstraZeneca$239
- Amgen$222
- Pfizer$203
- Novo Nordisk$192
- Lilly USA, LLC$158
- plus $796 from 20 others
What the payments were for
- Food & beverage$2,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 12 | $276 |
| AstraZeneca | 14 | $239 |
| Amgen | 19 | $222 |
| Pfizer | 12 | $203 |
| Novo Nordisk | 12 | $192 |
| Lilly USA, LLC | 9 | $158 |
| AbbVie | 6 | $142 |
| GSK | 7 | $114 |
| Astellas Pharma US Inc | 5 | $89 |
| Exact Sciences | 4 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Sunovion Pharmaceuticals Inc. | 3 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Globus Medical | 1 | $32 |
| Merck | 2 | $30 |
| Dexcom, Inc. | 1 | $29 |
| Novartis | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| GE HealthCare | 1 | $10 |
How this compares
$2,087 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 106 | $104,948 |
| JardianceEmpagliflozin | 133 | $104,176 |
| OzempicSemaglutide | 87 | $94,231 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 91 | $67,602 |
| MounjaroTirzepatide | 46 | $51,206 |
| TrulicityDulaglutide | 27 | $45,653 |
| MyrbetriqMirabegron | 67 | $38,414 |
| XareltoRivaroxaban | 28 | $26,269 |
| RybelsusSemaglutide | 16 | $24,199 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $20,689 |
| FarxigaDapagliflozin Propanediol | 22 | $17,738 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 27 | $17,492 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $10,858 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $9,930 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $16 | $127,982172 claims |
| Novo NordiskOzempic, Rybelsus | $192 | $118,431103 claims |
| PfizerEliquis | $203 | $104,948106 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort, Brilinta | $239 | $100,907157 claims |
| Lilly USA, LLCMounjaro, Trulicity | $158 | $96,85973 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Arexvy | $114 | $41,69582 claims |
| Astellas Pharma US IncMyrbetriq | $89 | $38,41467 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Branson West
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.